Sequences Within Fibrinogen and Intercellular Adhesion Molecule-1 (ICAM-1) Modulate Signals Required for Mitogenesis
Overview
Authors
Affiliations
The interaction of fibrinogen (Fg) with intercellular adhesion molecule-1 (ICAM) on B-lymphoid Raji cells results in mitogenesis (Gardiner, E. E., and D'Souza, S. E. (1997) J. Biol. Chem. 272, 15474-15480). Incubation of Raji with Fg resulted in the increased tyrosine phosphorylation of the receptor-associated tyrosine kinase, pp60(Src) and extracellular signal-regulated kinase-1 (ERK). The increase in ERK-1 phosphorylation was blocked by a peptide with sequence matching ICAM-1-(8-22) and corresponded to a decrease in ERK-1 enzymatic activity. 100 microM amounts of Fg peptide gamma-(117-133) caused an increase in tyrosine phosphorylation of ERK-1. These results are consistent with our previous report wherein ICAM-1-(8-22) blocked Fg-induced mitogenesis and Fg-gamma-(117-133) induced proliferation in Raji. The specific inhibitor of MEK, PD98059 (25 microM), abrogated the increased phosphorylation of ERK-1 and blocked Raji mitogenesis by >50%. Inhibitors of pp60(Src), geldanamycin (62 nM), and herbimycin A (2.5 microM) blocked >50% of Raji proliferation. These results indicate that the proliferation induced by Fg interactions with ICAM-1 is mediated in part by receptor-associated tyrosine kinases and ERK-1, and that the recognition sequences within Fg and ICAM-1 participate in the signaling process.
Kawana S, Suzuki O, Hashimoto Y J Clin Exp Hematop. 2024; 64(4):275-285.
PMID: 39603636 PMC: 11786156. DOI: 10.3960/jslrt.23002.
Neoplastic ICAM-1 protects lung carcinoma from apoptosis through ligation of fibrinogen.
Wang S, Wang J, Liu C, Yang L, Tan X, Chen S Cell Death Dis. 2024; 15(8):605.
PMID: 39168965 PMC: 11339363. DOI: 10.1038/s41419-024-06989-9.
Bui T, Wiesolek H, Sumagin R J Leukoc Biol. 2020; 108(3):787-799.
PMID: 32182390 PMC: 7977775. DOI: 10.1002/JLB.2MR0220-549R.
Hirz T, Matera E, Chettab K, Jordheim L, Mathe D, Evesque A Oncotarget. 2017; 8(42):72818-72834.
PMID: 29069828 PMC: 5641171. DOI: 10.18632/oncotarget.20350.
Garnacho C, Serrano D, Muro S J Pharmacol Exp Ther. 2011; 340(3):638-47.
PMID: 22160267 PMC: 3286316. DOI: 10.1124/jpet.111.185579.